Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Rachoń

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2002
Long-term therapy with recombinant human erythropoietin decreases percentage of CD152(+) lymphocytes in primary glomerulonephritis haemodialysis patientsPiotr Trzonkowski, Jolanta Myśliwska, Alicja Debska-Slizień, et al.
Environmental Pollution (Barking, Essex : 1987)|November 23, 2020
Serum bisphenol A analogues in women diagnosed with the polycystic ovary syndrome - is there an association?Joanna Jurewicz, Joanna Majewska, Andrzej Berg, et al.
The Science of the Total Environment|July 27, 2018
Determination of trace levels of eleven bisphenol A analogues in human blood serum by high performance liquid chromatography-tandem mass spectrometryKatarzyna Owczarek, Paweł Kubica, Błażej Kudłak, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 24, 2019
Identification of the metabolic fingerprints in women with polycystic ovary syndrome using the multiplatform metabolomics techniqueMagdalena Buszewska-Forajta, Dominik Rachoń, Anna Stefaniak, et al.
Reproductive Toxicology (Elmsford, N.Y.)|November 20, 2023
Bisphenol A analogues and metabolic syndrome in women with polycystic ovary syndromeJoanna Majewska, Andrzej Berg, Joanna Jurewicz, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 3, 2023
Searching for the primary metabolic alterations of polycystic ovary syndrome by application of the untargeted metabolomics approachAnna Rajska, Magdalena Buszewska-Forajta, Szymon Macioszek, et al.
Ecotoxicology and Environmental Safety|February 9, 2024
Assessment of baby disposable diapers application for urine collection and determination of phthalate metabolitesMarta Glinka, Katarzyna Jażdżewska, Christina Vakh, et al.
Journal of Chromatography. A|February 16, 2024
Determination of urinary androgens in women with polycystic ovary syndrome using LC-QqQ/MS and the application of thin film solid-phase microextraction (TF-SPME)Anna Rajska, Joanna Raczak-Gutknecht, Wiktoria Struck-Lewicka, et al.
Endokrynologia Polska|July 3, 2015
Polish Society of Endocrinology Position statement on endocrine disrupting chemicals (EDCs)Aleksandra Rutkowska, Dominik Rachoń, Andrzej Milewicz, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|February 21, 2004
[Influence of erythropoietin on immunological system of patients with chronic renal failure]Alicja Debska-Slizień, Bolesław Rutkowski, Jacek Manitius, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2002
Long-term therapy with recombinant human erythropoietin decreases percentage of CD152(+) lymphocytes in primary glomerulonephritis haemodialysis patientsPiotr Trzonkowski, Jolanta Myśliwska, Alicja Debska-Slizień, et al.
Environmental Pollution (Barking, Essex : 1987)|November 23, 2020
Serum bisphenol A analogues in women diagnosed with the polycystic ovary syndrome - is there an association?Joanna Jurewicz, Joanna Majewska, Andrzej Berg, et al.
The Science of the Total Environment|July 27, 2018
Determination of trace levels of eleven bisphenol A analogues in human blood serum by high performance liquid chromatography-tandem mass spectrometryKatarzyna Owczarek, Paweł Kubica, Błażej Kudłak, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 24, 2019
Identification of the metabolic fingerprints in women with polycystic ovary syndrome using the multiplatform metabolomics techniqueMagdalena Buszewska-Forajta, Dominik Rachoń, Anna Stefaniak, et al.
Reproductive Toxicology (Elmsford, N.Y.)|November 20, 2023
Bisphenol A analogues and metabolic syndrome in women with polycystic ovary syndromeJoanna Majewska, Andrzej Berg, Joanna Jurewicz, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 3, 2023
Searching for the primary metabolic alterations of polycystic ovary syndrome by application of the untargeted metabolomics approachAnna Rajska, Magdalena Buszewska-Forajta, Szymon Macioszek, et al.
Ecotoxicology and Environmental Safety|February 9, 2024
Assessment of baby disposable diapers application for urine collection and determination of phthalate metabolitesMarta Glinka, Katarzyna Jażdżewska, Christina Vakh, et al.
Journal of Chromatography. A|February 16, 2024
Determination of urinary androgens in women with polycystic ovary syndrome using LC-QqQ/MS and the application of thin film solid-phase microextraction (TF-SPME)Anna Rajska, Joanna Raczak-Gutknecht, Wiktoria Struck-Lewicka, et al.
Endokrynologia Polska|July 3, 2015
Polish Society of Endocrinology Position statement on endocrine disrupting chemicals (EDCs)Aleksandra Rutkowska, Dominik Rachoń, Andrzej Milewicz, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|February 21, 2004
[Influence of erythropoietin on immunological system of patients with chronic renal failure]Alicja Debska-Slizień, Bolesław Rutkowski, Jacek Manitius, et al.
Pageof 5